Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma

1. Blanes, M.
2. González, J.D.
3. Lahuerta, J.J.
4. Ribas, P.
5. Lorenzo, I.
6. Boluda, B.
7. Sanz, M.A.
8. De La Rubia, J.